Compare Aventis Pharma with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PIRAMAL ENTERPRISES - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PIRAMAL ENTERPRISES SANOFI INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 34.8 13.7 254.4% View Chart
P/BV x 6.1 0.9 701.6% View Chart
Dividend Yield % 1.4 2.0 70.1%  

Financials

 SANOFI INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
PIRAMAL ENTERPRISES
Mar-19
SANOFI INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6,8403,303 207.1%   
Low Rs4,6301,797 257.7%   
Sales per share (Unadj.) Rs1,203.1716.5 167.9%  
Earnings per share (Unadj.) Rs165.379.7 207.3%  
Cash flow per share (Unadj.) Rs209.9107.9 194.5%  
Dividends per share (Unadj.) Rs84.0028.00 300.0%  
Dividend yield (eoy) %1.51.1 133.4%  
Book value per share (Unadj.) Rs963.61,477.5 65.2%  
Shares outstanding (eoy) m23.03184.45 12.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.83.6 133.9%   
Avg P/E ratio x34.732.0 108.5%  
P/CF ratio (eoy) x27.323.6 115.7%  
Price / Book Value ratio x6.01.7 344.9%  
Dividend payout %50.835.1 144.7%   
Avg Mkt Cap Rs m132,078470,292 28.1%   
No. of employees `0003.37.8 42.2%   
Total wages/salary Rs m4,06822,504 18.1%   
Avg. sales/employee Rs Th8,393.816,899.4 49.7%   
Avg. wages/employee Rs Th1,232.42,877.7 42.8%   
Avg. net profit/employee Rs Th1,153.01,879.9 61.3%   
INCOME DATA
Net Sales Rs m27,708132,153 21.0%  
Other income Rs m8973,128 28.7%   
Total revenues Rs m28,605135,281 21.1%   
Gross profit Rs m6,23566,290 9.4%  
Depreciation Rs m1,0275,202 19.7%   
Interest Rs m744,097 0.0%   
Profit before tax Rs m6,09820,119 30.3%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2928,611 26.6%   
Profit after tax Rs m3,80614,701 25.9%  
Gross profit margin %22.550.2 44.9%  
Effective tax rate %37.642.8 87.8%   
Net profit margin %13.711.1 123.5%  
BALANCE SHEET DATA
Current assets Rs m15,922122,742 13.0%   
Current liabilities Rs m6,235310,810 2.0%   
Net working cap to sales %35.0-142.3 -24.6%  
Current ratio x2.60.4 646.6%  
Inventory Days Days6423 275.9%  
Debtors Days Days2139 53.7%  
Net fixed assets Rs m7,539116,904 6.4%   
Share capital Rs m230369 62.3%   
"Free" reserves Rs m21,962272,161 8.1%   
Net worth Rs m22,192272,530 8.1%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m29,839856,261 3.5%  
Interest coverage x872.11.5 59,890.3%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.90.2 601.7%   
Return on assets %12.86.9 186.1%  
Return on equity %17.25.4 317.9%  
Return on capital %27.512.4 221.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58715,200 49.9%   
Fx outflow Rs m7,1454,889 146.2%   
Net fx Rs m44210,312 4.3%   
CASH FLOW
From Operations Rs m3,739-115,975 -3.2%  
From Investments Rs m-731-8,265 8.8%  
From Financial Activity Rs m-1,972107,525 -1.8%  
Net Cashflow Rs m1,036-16,650 -6.2%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 4.0 360.0%  
FIIs % 14.6 26.6 54.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 16.5 63.6%  
Shareholders   15,184 93,274 16.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 14, 2019 02:19 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS